Preparation of tadalafil intermediates
    101.
    发明申请
    Preparation of tadalafil intermediates 审中-公开
    他达拉非中间体的制备

    公开(公告)号:US20060276652A1

    公开(公告)日:2006-12-07

    申请号:US11403582

    申请日:2006-04-12

    IPC分类号: C07D471/02

    CPC分类号: C07D471/04

    摘要: Provided is a process for preparing tadalafil intermediates in various solvents. Also provided is a method for converting said intermediates to tadalafil.

    摘要翻译: 提供了在各种溶剂中制备他达拉非中间体的方法。 还提供了将所述中间体转化为他达拉非的方法。

    Preparation of candesartan cilexetil
    104.
    发明授权
    Preparation of candesartan cilexetil 失效
    坎地沙坦cilexetil的制备

    公开(公告)号:US07098342B2

    公开(公告)日:2006-08-29

    申请号:US10968710

    申请日:2004-10-18

    IPC分类号: C07D403/08 C07D257/04

    CPC分类号: C07D403/10

    摘要: The invention encompasses processes for the synthesis of cilexetil trityl candesartan from the reaction of trityl candesartan with cilexetil halide in the presence of a base and a low boiling organic solvent. Optionally, the reaction may be conducted in the presence of a phase transfer catalyst.

    摘要翻译: 本发明包括在碱和低沸点有机溶剂的存在下,从三苯甲基坎地沙坦与碳酸吡哩啶卤化物的反应合成曲塞沙星三苯甲基坎地沙坦的方法。 任选地,反应可以在相转移催化剂的存在下进行。

    Processes for preparing losartan and losartan potassium
    106.
    发明授权
    Processes for preparing losartan and losartan potassium 失效
    制备氯沙坦和氯沙坦钾的方法

    公开(公告)号:US07041832B2

    公开(公告)日:2006-05-09

    申请号:US10426612

    申请日:2003-04-29

    申请人: Ben-Zion Dolitzky

    发明人: Ben-Zion Dolitzky

    IPC分类号: C07D257/00

    CPC分类号: C07D403/10

    摘要: Losartan is prepared by acid catalyzed cleavage of a triarylmethyl group from a triarylmethyl-substituted losartan derivative in a diluent comprising liquid ketone. The reaction mixture is basified and liquid ketone is evaporated from the mixture leaving a residue from which a triarylmethyl alcohol and losartan are each obtained in high yield and high purity. In addition, losartan potassium is prepared by a process that is more convenient that those previously known in the art in which losartan is contacted with potassium ions in substantially pure liquid alcohol and losartan potassium is precipitated from the alcohol.

    摘要翻译: 氯沙坦通过在包含液体酮的稀释剂中由三芳基甲基取代的氯沙坦衍生物进行酸催化裂解三芳基甲基来制备。 将反应混合物碱化,并从混合物中蒸发出液体酮,留下残余物,从中以高产率和高纯度各自获得三芳基甲醇和氯沙坦。 此外,氯沙坦钾通过以下方法制备,该方法比本领域已知的氯沙坦与基本上纯的液体醇中的钾离子和氯沙坦钾从醇中沉淀出来的方法更为方便。